Physician Profile
Thomas T. Amatruda, M.D.
Unclaimed ProfileAbout Dr. Amatruda
Based in Fridley, MN, Thomas T. Amatruda, M.D. is listed in the NPI registry under hematology & oncology. Thomas graduated from Yale University School of Medicine in 1978. According to Medicare claims data, Thomas cared for 664 Medicare patients across 16,107 services. The services billed most often include injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use), injection, pembrolizumab, 1 mg, and injection, denosumab, 1 mg.
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it.
Education & Training
Specialty
Credentials & Licensing
License numbers are what the provider reported to NPPES when the NPI was issued or updated. NPPES does not verify licensure; confirm current standing with the state licensing board.
Medicare information
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
Contact Information
- (763) 786-1620
- Email not available
Practice Locations
480 OSBORNE RD NE SUITE 220
Fridley, MN 55432
Conditions Commonly Evaluated or Treated
Within Hematology and Oncology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Conditions
Most searched conditions
- Anemia
- Blood clots
- Breast cancer
- Colon cancer
- Iron-deficiency anemia
- Leukemia
- Lung cancer
- Lymphoma
- Prostate cancer
Advanced Cancers
- Cancer That Has Spread
Blood & Lymph Disorders
- Enlarged spleen
- Swollen Lymph Nodes
Blood Cancers
- Multiple Myeloma
- Myelodysplastic Syndrome
Blood Disorders
- Bleeding Disorders
- Blood Clot in Lung
- Blood Clotting Gene Mutation
- Deep vein thrombosis
- Hemochromatosis
- High Platelet Count
- High White Blood Cell Count
- Low Platelets
- Low White Blood Cell Count
- Thick Blood
- Unexplained Bruising
Blood disorders
- Bone Marrow Scarring
- Hemolytic Anemia in Children
- Pre-Myeloma Protein In Blood
- Vitamin B12 deficiency anemia
Bone & Soft Tissue Cancers
- Bone tumors
- Soft-tissue sarcoma
Digestive Cancers
- Esophageal cancer
- Liver cancer
- Pancreatic cancer
- Stomach cancer
Endocrine Cancers
- Thyroid cancer
Endocrine tumors
- Neuroendocrine Tumors
Gastrointestinal cancer
- Anal cancer
- Appendix cancer
- Bile duct cancer
- Gallbladder cancer
General oncology
- Cancer of unknown primary
Genetic Blood Disorders
- Sickle cell disease
- Thalassemia
Gynecologic cancer
- Vulvar cancer
Gynecologic Cancers
- Cervical cancer
- Endometrial cancer
- Ovarian cancer
Head & Neck Cancers
- Oral cancer
Head and neck cancer
- Laryngeal cancer
- Oral cavity cancer
Neurologic Cancers
- Brain tumor
Oncologic emergencies
- High calcium from cancer
Ophthalmologic oncology
- Melanoma of the eye
Skin cancer
- Skin cancer
Skin Cancers
- Melanoma
Urologic Cancers
- Bladder cancer
- Kidney cancer
- Testicular cancer
Procedures & services
Most searched procedures
- Blood transfusion
- Chemotherapy
- Immunotherapy
- Targeted therapy
Biopsies & Diagnostics
- Bone Marrow Biopsy
- Lumbar puncture
- Lymph Node Biopsy
Blood disorder care
- Blood Exchange Transfusion
- Photopheresis
Cancer Therapies
- Hormone Therapy For Cancer
Cancer therapy
- Chemo allergy desensitization
- Oral chemotherapy management
- Radiation oncology consultation
- Spinal chemo injection
Cellular Therapies
- CAR-T Therapy
- Stem Cell Transplant
Consultations
- Cancer Survivorship Care Plan
- Clinical Trial Screening
- Second Opinion For Cancer
Diagnostic testing
- Circulating tumor cell test
Hematology Treatments
- Blood Clot Management
- Plasmapheresis
- PRP Injection
- Therapeutic Blood Draw
Imaging
- PET Scan
Infusions
- Clotting Factor Replacement
- Iron Infusion
- IV fluids
- IVIG Infusion
Interventional oncology
- Radiofrequency ablation
- TACE Chemoembolization
Supportive Cancer Care
- Bone Strengthening Injections For Cancer
- Pain Management For Cancer
- Red Blood Cell Booster Shot
- White Blood Cell Booster Injection
Supportive cancer care
- Cancer nutrition counseling
- Chemo brain treatment
- Cold cap therapy for hair loss
- Fertility Preservation for Teens Before Cancer Treatment
- Hyperbaric oxygen for radiation damage
- Lymphedema Drainage Therapy
- Palliative cancer care
Surgical & Vascular Access
- Chemo port placement
- Chemo port removal
- Draining lung fluid
- Paracentesis
- PICC line placement coordination
Testing & Genetics
- Cancer Genetic Testing
- Cancer Tumor Profiling
- Liquid Biopsy
Vascular access care
- Chemo port check
- Chemo Port Flush And Maintenance
- PICC line dressing change
Procedures Most Often Billed to Medicare
16,107 services · 664 patients · 24 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Insertion of needle into vein for collection of blood sample | Procedure | 36415 |
210 | Less often than most peers in Hematology & Oncology |
| Injection of additional new drug or substance into vein | Treatment | 96375 |
99 | Less often than most peers in Hematology & Oncology |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
76 | Less often than most peers in Hematology & Oncology |
| Injection of drug or substance under skin or into muscle | Treatment | 96372 |
70 | Less often than most peers in Hematology & Oncology |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Treatment | 96365 |
42 | Less often than most peers in Hematology & Oncology |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Treatment | 96402 |
19 | Less often than most peers in Hematology & Oncology |
| Injection, pembrolizumab, 1 mg | Drug given | J9271 |
5,100 | Less often than most peers in Hematology & Oncology |
| Injection, denosumab, 1 mg | Drug given | J0897 |
2,280 | Less often than most peers in Hematology & Oncology |
| Injection, dexamethasone sodium phosphate, 1 mg | Drug given | J1100 |
560 | Less often than most peers in Hematology & Oncology |
| Injection, granisetron hydrochloride, 100 mcg | Drug given | J1626 |
360 | Less often than most peers in Hematology & Oncology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Related providers
Connections drawn from the registry and from what providers have told us. A link here is not a referral or an endorsement.
Other cancer specialists at this location 1
Same specialty, same street address — most likely the same department or group.
Related specialists at this location 1
Clinically related specialties at the same address — the people this provider most likely works alongside.
Also at this address 4
Providers at the same street address. Each files their own registry entry, so a shared practice often appears under several different names.
More connections — 26 related providers in 4 groups
Other cancer specialists in Fridley 2
Same specialty, same city.
Trained at Yale University School of Medicine 8
Other providers in the same specialty who trained at the same institution.
Class of 1978 at Yale University School of Medicine 8
Providers who graduated from the same medical school in the same year.
Also performs Insertion of needle into vein for collection of blood sample 8
Providers in MN who bill this service to Medicare most often.
Common questions
What does Thomas T. Amatruda specialize in?
Thomas T. Amatruda is a cancer specialist in Fridley, MN. That is the designation recorded for this NPI in the federal registry, where it is listed as “Hematology & Oncology”.
NPI registry
Where is Thomas T. Amatruda located?
Thomas T. Amatruda is listed at 480 Osborne Rd Ne Suite 220, Fridley, MN 55432. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
What is Thomas T. Amatruda's phone number?
The number on file is (763) 786-1620. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
What is Thomas T. Amatruda's NPI number?
Thomas T. Amatruda's National Provider Identifier is 1427068618. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Where did Thomas T. Amatruda train?
Thomas T. Amatruda attended Yale University School of Medicine, graduating in 1978. This comes from the CMS National Downloadable File.
CMS public data
How long has Thomas T. Amatruda been practicing?
Thomas T. Amatruda has 48 years experience. Calculated from a graduation year of 1978, reported in the CMS National Downloadable File.
CMS public data
What does Thomas T. Amatruda do most often?
According to Medicare billing data, Thomas T. Amatruda performs procedures including insertion of needle into vein for collection of blood sample; provides treatments such as injection of additional new drug or substance into vein and administration of chemotherapy into vein, 1 hour or less, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Has Thomas T. Amatruda confirmed this information?
Not yet. This profile is built from public federal data and has not been confirmed by Thomas T. Amatruda. If this is you, claiming it is free.
Guide.md
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.